Incyte to Present at Upcoming Investor Conference

5/27/25 8:00:00 AM ET

Biotechnology: Commercial Physical & Biological Resarch

Health Care

Get the next $INCY alert in real time by email

Incyte (NASDAQ:INCY) announced today that it will present at the Goldman Sachs Healthcare Conference on Monday, June 9, 2025 at 11:20 am (ET).

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250527016922/en/

Incyte Contacts

Media

[email protected]

Investors

[email protected]

Get the next $INCY alert in real time by email

Date	Price Target	Rating	Analyst
6/16/2025	$107.00	Hold → Buy	Stifel
3/18/2025		Buy → Neutral	Guggenheim
3/18/2025		Outperform → Mkt Perform	William Blair
12/17/2024	$77.00	Neutral	UBS
10/29/2024	$68.00 → $90.00	Neutral → Buy	BofA Securities
10/1/2024	$84.00	Outperform	Wolfe Research
9/18/2024	$83.00 → $74.00	Buy → Hold	Truist
7/2/2024	$52.00 → $48.00	Market Perform → Underperform	BMO Capital Markets

Incyte to Present at Upcoming Investor Conference

Chat with this insight

Recent Analyst Ratings for
$INCY

Incyte to Present at Upcoming Investor Conference

Chat with this insight

Recent Analyst Ratings for $INCY

Recent Analyst Ratings for
$INCY